We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
+3.26%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$7.02B
AUM Growth
Cap. Flow
+$7.06B
Cap. Flow %
100.55%
Top 10 Hldgs %
35.63%
Holding
136
New
136
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$305M
2
HIG icon
Hartford Financial Services
HIG
+$280M
3
KO icon
Coca-Cola
KO
+$271M
4
HD icon
Home Depot
HD
+$264M
5
C icon
Citigroup
C
+$250M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Communication Services 14.69%
2 Consumer Discretionary 14.52%
3 Financials 13.79%
4 Industrials 9.55%
5 Consumer Staples 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIV
126
Aimco
AIV
$384M
$2.01M 0.03%
+502,566
New +$2.06M
CZZ
127
DELISTED
Cosan Limited
CZZ
$1.94M 0.03%
+120,200
New +$2.29M
BSBR icon
128
Santander
BSBR
$42.5B
$1.94M 0.03%
+325,624
New +$2.2M
XOM icon
129
ExxonMobil
XOM
$639B
$1.66M 0.02%
+18,313
New +$1.65M
EWM icon
130
iShares MSCI Malaysia ETF
EWM
$309M
$1.45M 0.02%
+23,225
New +$1.47M
FLOT icon
131
iShares Floating Rate Bond ETF
FLOT
$10.2B
$1.39M 0.02%
+27,500
New +$1.39M
EEM icon
132
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$1.38M 0.02%
+35,855
New +$1.49M
DEI icon
133
Douglas Emmett
DEI
$2B
$1.27M 0.02%
+51,084
New +$1.32M
KDP icon
134
Keurig Dr Pepper
KDP
$42.4B
$574K 0.01%
+12,500
New +$593K
FXI icon
135
iShares China Large-Cap ETF
FXI
$4.34B
$502K 0.01%
+15,431
New +$556K
INTC icon
136
Intel
INTC
$469B
$301K ﹤0.01%
+12,437
New +$294K

Similar funds

Sarasin & Partners's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Sarasin & Partners, which disclosed 136 positions worth $7.02B. Its ten largest holdings account for 36% of the portfolio.

Its largest position is Pfizer: 11,040,890 shares worth $293M.

By sector, the portfolio is most concentrated in Communication Services at 15% of assets, followed by Consumer Discretionary and Financials.

  • Sarasin & Partners's largest Q2 2013 buy was Pfizer: 11,040,890 shares worth $293M.
  • Sarasin & Partners's ten largest holdings make up 36% of its $7.02B portfolio in Q2 2013.
  • Sarasin & Partners disclosed 136 positions in Q2 2013, its first 13F filing on record.

Based on Sarasin & Partners's 13F filing for Q2 2013, filed 7 Aug 2013.